Press ReleaseHox Therapeutics and Vernalis announce a drug discovery collaboration in oncology CHENGDU, China, Feb. 20, 2024 /PRNewswire/ — Hox Therapeutics Ltd ("Hox") a private… CISION PRNewswireFebruary 20, 2024
Press ReleaseWestwell Announces the Establishment of International Headquarters and Overseas R&D Center in Hong Kong HONG KONG, Feb. 20, 2024 /PRNewswire/ — Witnessed by the Innovation, Technology… CISION PRNewswireFebruary 20, 2024
Press ReleaseSupermicro Drives Advanced AI Capabilities to Edge Computing Environments with New Industry-Leading System Portfolio Remote Edge Computing Require High-Performance AI and Training Solutions to Support Advanced… CISION PRNewswireFebruary 20, 2024
Press ReleaseTechSenmiao Technology's XXTX Online Ride-hailing Platform Receives Highest Rating for Service Quality and Reputation in Changsha CHENGDU, China, Feb. 20, 2024 /PRNewswire/ — Senmiao Technology Limited ("Senmiao" or… CISION PRNewswireFebruary 20, 2024
Press ReleaseFranklinWH and Solar Insure Partner to Elevate and Protect Whole-Home Energy Management The FranklinWH will officially be listed on Solar Insure’s Approved Vendor List… CISION PRNewswireFebruary 20, 2024
Press ReleaseAUTOCRYPT Launches Cybersecurity Testing Platform for UN R155/156 and GB Compliance New platform enables automotive OEMs to conduct regulatory compliant security testing and… CISION PRNewswireFebruary 20, 2024
Press ReleaseMabwell Receives IND Approval from FDA for Novel B7-H3 ADC 7MW3711 SHANGHAI, Feb. 20, 2024 /PRNewswire/ — Mabwell (688062.SH), an innovative biopharmaceutical company… CISION PRNewswireFebruary 20, 2024
Press ReleaseFDA Grants Orphan Drug Designation to 9MW3011 SHANGHAI, Feb. 20, 2024 /PRNewswire/ — Mabwell (688062.SH), an innovative biopharmaceutical company… CISION PRNewswireFebruary 20, 2024
